{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:56:10Z","timestamp":1790607370439,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lab Anim"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In men, cystic fibrosis (CF) leads to infertility in over 95% of cases, due to early and progressive atresia of the vas deferens, resulting in obstructive azoospermia. The advent of highly effective modulator therapy has enabled more men with CF to consider parenthood, raising important questions regarding the impact of these treatments on male fertility. Animal models provide major insights into the mechanism of CF-related reproductive tract abnormalities, yet high interspecies variability complicates model selection. Mouse models display heterogeneous phenotype: knock-in or partial knockout models usually remain fertile, whereas complete knockouts may develop vas deferens atresia with aging. Among currently studied models, CF transmembrane conductance regulator (CFTR)-knockout rats more closely reproduce the human phenotype, showing bilateral absence of the vas deferens and epididymal hypoplasia, although they exhibit more pronounced hypospermatogenesis than observed in men. In larger animal models, including ferrets, pigs, sheep and rabbits, absence of the vas deferens duct and epididymis is frequently observed, often with normal testicular histology; however, most studies in these species have mainly focused on neonatal stages, leaving long-term reproductive outcomes uncharacterized. No single model fully replicates human male reproductive pathology in CF. Combining rodent and large-animal models is probably essential to elucidate the mechanisms of vas deferens absence and to assess the long-term effects of CFTR modulators on male spermatogenesis and reproductive outcomes.<\/jats:p>","DOI":"10.1038\/s41684-026-01763-0","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T10:22:36Z","timestamp":1782814956000},"page":"379-385","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Male reproductive phenotype in cystic fibrosis: comparison of existing animal models"],"prefix":"10.1038","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8548-4961","authenticated-orcid":false,"given":"Ang\u00e8le","family":"Boursier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3776-957X","authenticated-orcid":false,"given":"Charles-Henry","family":"Cottart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aissatu","family":"Balde-Camara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Vialard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Laure","family":"Barbotin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"1763_CR1","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1126\/science.2570460","volume":"245","author":"B Kerem","year":"1989","unstructured":"Kerem, B. et al. Identification of the cystic fibrosis gene: genetic analysis. Science 245, 1073\u20131080 (1989).","journal-title":"Science"},{"key":"1763_CR2","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00018-016-2393-9","volume":"74","author":"C Castellani","year":"2017","unstructured":"Castellani, C. & Assael, B. M. Cystic fibrosis: a clinical view. Cell. Mol. Life Sci. 74, 129\u2013140 (2017).","journal-title":"Cell. Mol. Life Sci."},{"key":"1763_CR3","doi-asserted-by":"publisher","first-page":"775123","DOI":"10.3389\/fgene.2022.775123","volume":"13","author":"Z Cai","year":"2022","unstructured":"Cai, Z. & Li, H. Congenital bilateral absence of the vas deferens. Front. Genet. 13, 775123 (2022).","journal-title":"Front. Genet."},{"key":"1763_CR4","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.humpath.2011.04.031","volume":"43","author":"P Marcorelles","year":"2012","unstructured":"Marcorelles, P. et al. Cystic fibrosis transmembrane conductance regulator protein expression in the male excretory duct system during development. Hum. Pathol. 43, 390\u2013397 (2012).","journal-title":"Hum. Pathol."},{"key":"1763_CR5","doi-asserted-by":"crossref","unstructured":"The management of obstructive azoospermia: a committee opinion. Fertil. Steril. 111, 873\u2013880 (2019).","DOI":"10.1016\/j.fertnstert.2019.02.013"},{"key":"1763_CR6","doi-asserted-by":"publisher","first-page":"105042","DOI":"10.1016\/j.rbmo.2025.105042","volume":"51","author":"A Boursier","year":"2025","unstructured":"Boursier, A. et al. Cystic fibrosis: influence of CFTR variants on epididymal sperm recovery and ICSI results. Reprod. Biomed. Online. 51, 105042 (2025).","journal-title":"Reprod. Biomed. Online."},{"key":"1763_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1046\/j.1439-0272.2000.00327.x","volume":"32","author":"M Stuhrmann","year":"2000","unstructured":"Stuhrmann, M. & D\u00f6rk, T. CFTR gene mutations and male infertility. Andrologia 32, 71\u201383 (2000).","journal-title":"Andrologia"},{"key":"1763_CR8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jcf.2006.03.004","volume":"5","author":"I Dugu\u00e9p\u00e9roux","year":"2006","unstructured":"Dugu\u00e9p\u00e9roux, I. et al. Paternity in men with cystic fibrosis: a retrospective survey in France. J. Cyst. Fibros. 5, 215\u2013221 (2006).","journal-title":"J. Cyst. Fibros."},{"key":"1763_CR9","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1530\/rep.1.00964","volume":"133","author":"M Kujala","year":"2007","unstructured":"Kujala, M. et al. Expression of ion transport-associated proteins in human efferent and epididymal ducts. Reproduction 133, 775\u2013784 (2007).","journal-title":"Reproduction"},{"key":"1763_CR10","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1111\/andr.13477","volume":"12","author":"S-H Leir","year":"2024","unstructured":"Leir, S.-H., Paranjapye, A. & Harris, A. Functional genomics of the human epididymis: further characterization of efferent ducts and model systems by single-cell RNA sequencing analysis. Andrology 12, 991\u20131000 (2024).","journal-title":"Andrology"},{"key":"1763_CR11","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.3390\/ijms22063264","volume":"22","author":"F Cioppi","year":"2021","unstructured":"Cioppi, F., Rosta, V. & Krausz, C. Genetics of azoospermia. Int. J. Mol. Sci. 22, 3264 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1763_CR12","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/S0015-0282(98)00247-7","volume":"70","author":"K Jarvi","year":"1998","unstructured":"Jarvi, K. et al. Heterogeneity of reproductive tract abnormalities in men with absence of the vas deferens: role of cystic fibrosis transmembrane conductance regulator gene mutations. Fertil. Steril. 70, 724\u2013728 (1998).","journal-title":"Fertil. Steril."},{"key":"1763_CR13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1136\/adc.87.2.135","volume":"87","author":"H Blau","year":"2002","unstructured":"Blau, H. et al. Urogenital abnormalities in male children with cystic fibrosis. Arch. Dis. Child. 87, 135\u2013138 (2002).","journal-title":"Arch. Dis. Child."},{"key":"1763_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.urology.2023.08.039","volume":"182","author":"K Campbell","year":"2023","unstructured":"Campbell, K. et al. Prevalence of low testosterone in men with cystic fibrosis and congenital bilateral absence of the vas deferens: a cross-sectional study using a large, multi-institutional database. Urology 182, 143\u2013148 (2023).","journal-title":"Urology"},{"key":"1763_CR15","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.3389\/fphar.2019.01662","volume":"10","author":"M Lopes-Pacheco","year":"2019","unstructured":"Lopes-Pacheco, M. CFTR modulators: the changing face of cystic fibrosis in the era of precision medicine. Front. Pharmacol. 10, 1662 (2019).","journal-title":"Front. Pharmacol."},{"key":"1763_CR16","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.jcf.2024.06.003","volume":"23","author":"A Kowalik","year":"2024","unstructured":"Kowalik, A. et al. Clinical outcomes of two infants with cystic fibrosis, including presence of the vas deferens, born to a woman with cystic fibrosis taking CFTR modulators during both pregnancies. J. Cyst. Fibros. 23, 1027\u20131030 (2024).","journal-title":"J. Cyst. Fibros."},{"key":"1763_CR17","doi-asserted-by":"publisher","unstructured":"Thee, S. et al. Prenatal initiation of elexacaftor\/tezacaftor\/ivacaftor via carrier mother prevents congenital bilateral absence of vas deferens in a male infant with cystic fibrosis. J. Cyst. Fibros. https:\/\/doi.org\/10.1016\/j.jcf.2026.02.001 (2026).","DOI":"10.1016\/j.jcf.2026.02.001"},{"key":"1763_CR18","doi-asserted-by":"publisher","unstructured":"Gautier, S. et al. Pregnancy and neonatal outcome following in utero exposure to CFTR modulators: A multicentre prospective case series. J. Cyst. Fibros. https:\/\/doi.org\/10.1016\/j.jcf.2025.06.001 (2025).","DOI":"10.1016\/j.jcf.2025.06.001"},{"key":"1763_CR19","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1586\/14737159.7.4.407","volume":"7","author":"I Carvalho-Oliveira","year":"2007","unstructured":"Carvalho-Oliveira, I., Scholte, B. J. & Penque, D. What have we learned from mouse models for cystic fibrosis? Expert Rev. Mol. Diagn. 7, 407\u2013417 (2007).","journal-title":"Expert Rev. Mol. Diagn."},{"key":"1763_CR20","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1126\/science.257.5073.1083","volume":"257","author":"JN Snouwaert","year":"1992","unstructured":"Snouwaert, J. N. et al. An animal model for cystic fibrosis made by gene targeting. Science 257, 1083\u20131088 (1992).","journal-title":"Science"},{"key":"1763_CR21","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3389\/fphar.2018.01475","volume":"9","author":"A Semaniakou","year":"2018","unstructured":"Semaniakou, A., Croll, R. P. & Chappe, V. Animal models in the pathophysiology of cystic fibrosis. Front. Pharmacol. 9, 1475 (2018).","journal-title":"Front. Pharmacol."},{"key":"1763_CR22","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0888-7543(91)90312-3","volume":"10","author":"F Tata","year":"1991","unstructured":"Tata, F. et al. Cloning the mouse homolog of the human cystic fibrosis transmembrane conductance regulator gene. Genomics 10, 301\u2013307 (1991).","journal-title":"Genomics"},{"key":"1763_CR23","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1093\/humupd\/dmw015","volume":"22","author":"R Sullivan","year":"2016","unstructured":"Sullivan, R. & Mieusset, R. The human epididymis: its function in sperm maturation. Hum. Reprod. Update 22, 574\u2013587 (2016).","journal-title":"Hum. Reprod. Update"},{"key":"1763_CR24","doi-asserted-by":"publisher","first-page":"4403","DOI":"10.1002\/j.1460-2075.1995.tb00119.x","volume":"14","author":"JH van Doorninck","year":"1995","unstructured":"van Doorninck, J. H. et al. A mouse model for the cystic fibrosis delta F508 mutation. EMBO J. 14, 4403\u20134411 (1995).","journal-title":"EMBO J."},{"key":"1763_CR25","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1172\/JCI118253","volume":"96","author":"BG Zeiher","year":"1995","unstructured":"Zeiher, B. G. et al. A mouse model for the delta F508 allele of cystic fibrosis. J. Clin. Invest. 96, 2051\u20132064 (1995).","journal-title":"J. Clin. Invest."},{"key":"1763_CR26","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/j.1460-2075.1996.tb00432.x","volume":"15","author":"SJ Delaney","year":"1996","unstructured":"Delaney, S. J. et al. Cystic fibrosis mice carrying the missense mutation G551D replicate human genotype\u2013phenotype correlations. EMBO J. 15, 955\u2013963 (1996).","journal-title":"EMBO J."},{"key":"1763_CR27","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/hmg\/11.3.243","volume":"11","author":"P Dickinson","year":"2002","unstructured":"Dickinson, P. et al. The severe G480C cystic fibrosis mutation, when replicated in the mouse, demonstrates mistrafficking, normal survival and organ-specific bioelectrics. Hum. Mol. Genet. 11, 243\u2013251 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"1763_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/(SICI)1098-2795(200002)55:2<125::AID-MRD1>3.0.CO;2-Q","volume":"55","author":"I Reynaert","year":"2000","unstructured":"Reynaert, I. et al. Morphological changes in the vas deferens and expression of the cystic fibrosis transmembrane conductance regulator (CFTR) in control, deltaF508 and knock-out CFTR mice during postnatal life. Mol. Reprod. Dev. 55, 125\u2013135 (2000).","journal-title":"Mol. Reprod. Dev."},{"key":"1763_CR29","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1093\/hmg\/2.10.1561","volume":"2","author":"WK O\u2019Neal","year":"1993","unstructured":"O\u2019Neal, W. K. et al. A severe phenotype in mice with a duplication of exon 3 in the cystic fibrosis locus. Hum. Mol. Genet. 2, 1561\u20131569 (1993).","journal-title":"Hum. Mol. Genet."},{"key":"1763_CR30","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/359211a0","volume":"359","author":"JR Dorin","year":"1992","unstructured":"Dorin, J. R. et al. Cystic fibrosis in the mouse by targeted insertional mutagenesis. Nature 359, 211\u2013215 (1992).","journal-title":"Nature"},{"key":"1763_CR31","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1203\/00006450-199608000-00008","volume":"40","author":"G Kent","year":"1996","unstructured":"Kent, G. et al. Phenotypic abnormalities in long-term surviving cystic fibrosis mice. Pediatr. Res. 40, 233\u2013241 (1996).","journal-title":"Pediatr. Res."},{"key":"1763_CR32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/BF02254769","volume":"21","author":"P Hasty","year":"1995","unstructured":"Hasty, P. et al. Severe phenotype in mice with termination mutation in exon 2 of cystic fibrosis gene. Somat. Cell Mol. Genet. 21, 177\u2013187 (1995).","journal-title":"Somat. Cell Mol. Genet."},{"key":"1763_CR33","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/S0002-9440(10)63234-8","volume":"164","author":"PR Durie","year":"2004","unstructured":"Durie, P. R., Kent, G., Phillips, M. J. & Ackerley, C. A. Characteristic multiorgan pathology of cystic fibrosis in a long-living cystic fibrosis transmembrane regulator knockout murine model. Am. J. Pathol. 164, 1481\u20131493 (2004).","journal-title":"Am. J. Pathol."},{"key":"1763_CR34","doi-asserted-by":"publisher","first-page":"e19120","DOI":"10.1371\/journal.pone.0019120","volume":"6","author":"WM Xu","year":"2011","unstructured":"Xu, W. M. et al. Defective CFTR-dependent CREB activation results in impaired spermatogenesis and azoospermia. PLoS ONE 6, e19120 (2011).","journal-title":"PLoS ONE"},{"key":"1763_CR35","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1164\/ajrccm\/151.3_Pt_2.S59","volume":"151","author":"JN Snouwaert","year":"1995","unstructured":"Snouwaert, J. N. et al. A murine model of cystic fibrosis. Am. J. Respir. Crit. Care Med. 151, S59\u2013S64 (1995).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"1763_CR36","doi-asserted-by":"publisher","first-page":"e91253","DOI":"10.1371\/journal.pone.0091253","volume":"9","author":"KL Tuggle","year":"2014","unstructured":"Tuggle, K. L. et al. Characterization of defects in ion transport and tissue development in cystic fibrosis transmembrane conductance regulator (CFTR)-knockout rats. PLoS ONE 9, e91253 (2014).","journal-title":"PLoS ONE"},{"key":"1763_CR37","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.ajpath.2020.01.009","volume":"190","author":"A McCarron","year":"2020","unstructured":"McCarron, A. et al. Phenotypic characterization and comparison of cystic fibrosis rat models generated using CRISPR\/Cas9 gene editing. Am. J. Pathol. 190, 977\u2013993 (2020).","journal-title":"Am. J. Pathol."},{"key":"1763_CR38","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/ame2.12091","volume":"2","author":"E Dreano","year":"2019","unstructured":"Dreano, E. et al. Characterization of two rat models of cystic fibrosis\u2014KO and F508del CFTR\u2014generated by CRISPR\u2013Cas9. Anim. Models Exp. Med. 2, 297\u2013311 (2019).","journal-title":"Anim. Models Exp. Med."},{"key":"1763_CR39","doi-asserted-by":"publisher","first-page":"e139813, 139813","DOI":"10.1172\/jci.insight.139813","volume":"6","author":"J Xu","year":"2021","unstructured":"Xu, J. et al. Phenotypes of CF rabbits generated by CRISPR\/Cas9-mediated disruption of the CFTR gene. JCI Insight 6, e139813, 139813 (2021).","journal-title":"JCI Insight"},{"key":"1763_CR40","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1172\/JCI34599","volume":"118","author":"X Sun","year":"2008","unstructured":"Sun, X. et al. Adeno-associated virus-targeted disruption of the CFTR gene in cloned ferrets. J. Clin. Invest. 118, 1578\u20131583 (2008).","journal-title":"J. Clin. Invest."},{"key":"1763_CR41","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1172\/JCI43052","volume":"120","author":"X Sun","year":"2010","unstructured":"Sun, X. et al. Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis. J. Clin. Invest. 120, 3149\u20133160 (2010).","journal-title":"J. Clin. Invest."},{"key":"1763_CR42","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau7531","volume":"11","author":"X Sun","year":"2019","unstructured":"Sun, X. et al. In utero and postnatal VX-770 administration rescues multi-organ disease in a ferret model of cystic fibrosis. Sci. Transl. Med. 11, eaau7531 (2019).","journal-title":"Sci. Transl. Med."},{"key":"1763_CR43","doi-asserted-by":"publisher","first-page":"e123529","DOI":"10.1172\/jci.insight.123529","volume":"3","author":"Z Fan","year":"2018","unstructured":"Fan, Z. et al. A sheep model of cystic fibrosis generated by CRISPR\/Cas9 disruption of the CFTR gene. JCI Insight 3, e123529 (2018).","journal-title":"JCI Insight"},{"key":"1763_CR44","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1126\/science.1163600","volume":"321","author":"CS Rogers","year":"2008","unstructured":"Rogers, C. S. et al. Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs. Science 321, 1837\u20131841 (2008).","journal-title":"Science"},{"key":"1763_CR45","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1095\/biolreprod.111.090860","volume":"85","author":"F Pierucci-Alves","year":"2011","unstructured":"Pierucci-Alves, F. et al. Swine models of cystic fibrosis reveal male reproductive tract phenotype at birth. Biol. Reprod. 85, 442\u2013451 (2011).","journal-title":"Biol. Reprod."},{"key":"1763_CR46","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00109-011-0839-y","volume":"90","author":"N Klymiuk","year":"2012","unstructured":"Klymiuk, N. et al. Sequential targeting of CFTR by BAC vectors generates a novel pig model of cystic fibrosis. J. Mol. Med. Berl. Ger. 90, 597\u2013608 (2012).","journal-title":"J. Mol. Med. Berl. Ger."},{"key":"1763_CR47","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1073\/pnas.91.2.479","volume":"91","author":"LL Clarke","year":"1994","unstructured":"Clarke, L. L. et al. Relationship of a non-cystic fibrosis transmembrane conductance regulator-mediated chloride conductance to organ-level disease in Cftr(\u2212\/\u2212) mice. Proc. Natl Acad. Sci. USA 91, 479\u2013483 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1763_CR48","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.mod.2018.10.002","volume":"155","author":"ZE Plyler","year":"2019","unstructured":"Plyler, Z. E. et al. Non-obstructive vas deferens and epididymis loss in cystic fibrosis rats. Mech. Dev. 155, 15\u201326 (2019).","journal-title":"Mech. Dev."},{"key":"1763_CR49","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00441-020-03208-7","volume":"381","author":"S-H Leir","year":"2020","unstructured":"Leir, S.-H. et al. An organoid model to assay the role of CFTR in the human epididymis epithelium. Cell Tissue Res. 381, 327\u2013336 (2020).","journal-title":"Cell Tissue Res."},{"key":"1763_CR50","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1002\/jum.15500","volume":"40","author":"S Gokhale","year":"2021","unstructured":"Gokhale, S. & Kochhar, K. Epididymal appearance in congenital absence of vas deferens. J. Ultrasound Med. 40, 1085\u20131090 (2021).","journal-title":"J. Ultrasound Med."},{"key":"1763_CR51","first-page":"4396","volume":"127","author":"YC Ruan","year":"2014","unstructured":"Ruan, Y. C. et al. CFTR interacts with ZO-1 to regulate tight junction assembly and epithelial differentiation through the ZONAB pathway. J. Cell Sci. 127, 4396\u20134408 (2014).","journal-title":"J. Cell Sci."},{"key":"1763_CR52","doi-asserted-by":"publisher","first-page":"102235","DOI":"10.1016\/j.coph.2022.102235","volume":"64","author":"BR Grubb","year":"2022","unstructured":"Grubb, B. R. & Livraghi-Butrico, A. Animal models of cystic fibrosis in the era of highly effective modulator therapies. Curr. Opin. Pharmacol. 64, 102235 (2022).","journal-title":"Curr. Opin. Pharmacol."},{"key":"1763_CR53","doi-asserted-by":"publisher","first-page":"1362325","DOI":"10.3389\/fphar.2024.1362325","volume":"15","author":"N Reyne","year":"2024","unstructured":"Reyne, N. et al. Effect of elexacaftor\u2013tezacaftor\u2013ivacaftor on nasal potential difference and lung function in Phe508del rats. Front. Pharmacol. 15, 1362325 (2024).","journal-title":"Front. Pharmacol."},{"key":"1763_CR54","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1164\/rccm.202002-0369OC","volume":"202","author":"SE Birket","year":"2020","unstructured":"Birket, S. E. et al. Ivacaftor reverses airway mucus abnormalities in a rat model harboring a humanized G551D-CFTR. Am. J. Respir. Crit. Care Med. 202, 1271\u20131282 (2020).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"1763_CR55","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ajpath.2020.10.017","volume":"191","author":"A McCarron","year":"2021","unstructured":"McCarron, A., Parsons, D. & Donnelley, M. Animal and cell culture models for cystic fibrosis: which model is right for your application? Am. J. Pathol. 191, 228\u2013242 (2021).","journal-title":"Am. J. Pathol."}],"container-title":["Lab Animal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41684-026-01763-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41684-026-01763-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41684-026-01763-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:02:15Z","timestamp":1790604135000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41684-026-01763-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":55,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1763"],"URL":"https:\/\/doi.org\/10.1038\/s41684-026-01763-0","relation":{},"ISSN":["0093-7355","1548-4475"],"issn-type":[{"value":"0093-7355","type":"print"},{"value":"1548-4475","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"24 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.B. reports having received a speaker fee from Merck Laboratory for a presentation unrelated to the topic of this Review. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}